2025-05-02 08:57:23
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Titan Biotech Ltd reports consolidated PAT of Rs. 6.39 crore in Q2FY22
Posted On : 2021-11-16 21:45:08( TIMEZONE : IST )
TITAN BIOTECH LTD. has reported Consolidated financial results for the period ended September 30, 2021.
Financial Results (Q2 FY2022) - QoQ Comparison
The company has reported total income of Rs. 41.1118 crores during the period ended September 30, 2021 as compared to Rs. 41.5832 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs. 6.3923 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 8.7232 crores for the period ended June 30, 2021.
The company has reported EPS of Rs. 7.74 for the period ended September 30, 2021 as compared to Rs. 10.56 for the period ended June 30, 2021.
| Financials | Q2 FY2022 | Q1 FY2022 | % Change |
| Total Income | ₹ 41.1118 crs | ₹41.5832 crs |  -1.13% |
| Net Profit | ₹6.3923 crs | ₹ 8.7232 crs | -26.72% |
| EPS | ₹7.74 | ₹10.56 | -26.70% |
Financial Results (Q2 FY2022) - YoY Comparison
The company has reported total income of Rs. 41.1118 crores during the period ended September 30, 2021 as compared to Rs.32.8218 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.6.3923 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.7.2099 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.7.74 for the period ended September 30, 2021 as compared to Rs.8.72 for the period ended September 30, 2020.
| Financials | Q2 FY2022 | Q2 FY2021 | % Change |
| Total Income | ₹ 41.1118 crs | ₹32.8218 crs |  25.26% |
| Net Profit | ₹6.3923 crs | ₹7.2099 crs | -11.34% |
| EPS | ₹7.74 | ₹8.72 | -11.24% |
Financial Results (Half Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.82.6950 crores during the 6 Months period ended September 30, 2021 as compared to Rs.72.4740 crores during the 6 Months period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.15.1155 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.19.9493 crores for the 6 Months period ended September 30, 2020.
The company has reported EPS of Rs.18.29 for the 6 Months period ended September 30, 2021 as compared to Rs.24.14 for the 6 Months period ended September 30, 2020.
| Financials | Half Year Ended FY2022 | Half Year Ended FY2021 | % Change |
| Total Income | ₹82.6950 crs | ₹72.4740 crs | 14.10% |
| Net Profit | ₹15.1155 crs | ₹19.9493 crs | -24.23% |
| EPS | ₹18.29 | ₹24.14 | -24.23% |
Shares of TITAN BIOTECH LTD. was last trading in BSE at Rs. 279.15 as compared to the previous close of Rs. 281.05. The total number of shares traded during the day was 18696 in over 850 trades.
The stock hit an intraday high of Rs. 289.05 and intraday low of 277.00. The net turnover during the day was Rs. 5265595.00.
